We conducted further subgroup analyses based on the sample size (Figure S2A), period of insulin treatment (Figure S2B), and type of diabetes (Figure S2C), but moderate/high heterogeneity remained in all subgroups. This evidence concerns the gene INS and diabetes mellitus.